Coronary venous retroinfusion of procainamide: A new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction-Reference-Cited by-同舟云学术

Coronary venous retroinfusion of procainamide: A new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction

Published:1986-03 Issue:3 Volume:7 Page:551-563
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Karagueuzian Hrayr S.,Ohta Masao,Drury J. Kevin,Fishbein Michael C.,Meerbaum Samuel,Corday Eliot,Mandel William J.,Peter Thomas

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference36 articles.

1. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia. Efficacy and electrophysiologic effects;Ross;Circulation,1982

2. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia;Mason;Circulation,1978

3. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications;Waxman;Circulation,1982

4. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs;Graboys;Am J Cardiol,1982

5. Inducible sustained ventricular tachycardia refractory to individual class I drugs: effects of adding a second class I drug;Duffy;Am Heart J,1983

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in gene therapy approaches for atrial fibrillation: Targeted delivery, mechanistic insights and future prospects;Current Problems in Cardiology;2024-04

2. Recent advances in gene therapy for atrial fibrillation;Journal of Cardiovascular Electrophysiology;2021-07-06

3. Gene Therapy for Cardiovascular Diseases;Stem Cell and Gene Therapy for Cardiovascular Disease;2016

4. Cardiac SERCA2A/B: Therapeutic targets for heart failure;European Journal of Pharmacology;2014-02

5. Gene- and Cell-Based Therapy for Cardiovascular Disease;Post-Genomic Cardiology;2014